<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>5882</number>
    <updateDate>2022-02-08T23:20:34Z</updateDate>
    <updateDateIncludingText>2022-02-08T23:20:34Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <type>HR</type>
    <introducedDate>2020-02-12</introducedDate>
    <congress>116</congress>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 166, Number 29 (Wednesday, February 12, 2020)][House]From the Congressional Record Online through the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]By Mr. SCHRADER:H.R. 5882.Congress has the power to enact this legislation pursuantto the following:Article I, Section I; and Article I, Section 8, Clause 18of the United States Constitution.[Page H1125]</pre>]]></constitutionalAuthorityStatementText>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2020-02-12T15:05:15Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Lower Costs, More Cures Act of 2019</title>
        <congress>116</congress>
        <number>19</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2019-12-19</actionDate>
          <text>Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Prescription Drug Pricing Reduction Act of 2019</title>
        <congress>116</congress>
        <number>2543</number>
        <type>S</type>
        <latestAction>
          <actionDate>2019-09-25</actionDate>
          <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 225.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Prescription Drug Pricing Reduction Act of 2020</title>
        <congress>116</congress>
        <number>4199</number>
        <type>S</type>
        <latestAction>
          <actionDate>2020-07-02</actionDate>
          <text>Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4228)</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2020-02-12</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2020-02-12</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2020-02-12</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>S001180</bioguideId>
        <fullName>Rep. Schrader, Kurt [D-OR-5]</fullName>
        <firstName>Kurt</firstName>
        <lastName>Schrader</lastName>
        <party>D</party>
        <state>OR</state>
        <district>5</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>M001198</bioguideId>
        <fullName>Rep. Marshall, Roger [R-KS-1]</fullName>
        <firstName>Roger</firstName>
        <lastName>Marshall</lastName>
        <party>R</party>
        <state>KS</state>
        <district>1</district>
        <sponsorshipDate>2020-02-12</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001121</bioguideId>
        <fullName>Rep. Crow, Jason [D-CO-6]</fullName>
        <firstName>Jason</firstName>
        <lastName>Crow</lastName>
        <party>D</party>
        <state>CO</state>
        <district>6</district>
        <sponsorshipDate>2020-02-12</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M001190</bioguideId>
        <fullName>Rep. Mullin, Markwayne [R-OK-2]</fullName>
        <firstName>Markwayne</firstName>
        <lastName>Mullin</lastName>
        <party>R</party>
        <state>OK</state>
        <district>2</district>
        <sponsorshipDate>2020-02-12</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001287</bioguideId>
        <fullName>Rep. Bera, Ami [D-CA-7]</fullName>
        <firstName>Ami</firstName>
        <lastName>Bera</lastName>
        <party>D</party>
        <state>CA</state>
        <district>7</district>
        <sponsorshipDate>2020-02-12</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>K000376</bioguideId>
        <fullName>Rep. Kelly, Mike [R-PA-16]</fullName>
        <firstName>Mike</firstName>
        <lastName>Kelly</lastName>
        <party>R</party>
        <state>PA</state>
        <district>16</district>
        <sponsorshipDate>2020-02-12</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>S001183</bioguideId>
        <fullName>Rep. Schweikert, David [R-AZ-6]</fullName>
        <firstName>David</firstName>
        <lastName>Schweikert</lastName>
        <party>R</party>
        <state>AZ</state>
        <district>6</district>
        <sponsorshipDate>2020-02-12</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative law and regulatory procedures</name>
        </item>
        <item>
          <name>Appropriations</name>
        </item>
        <item>
          <name>Congressional oversight</name>
        </item>
        <item>
          <name>Department of Health and Human Services</name>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
        </item>
        <item>
          <name>Drug therapy</name>
        </item>
        <item>
          <name>Genetics</name>
        </item>
        <item>
          <name>Government studies and investigations</name>
        </item>
        <item>
          <name>Health care costs and insurance</name>
        </item>
        <item>
          <name>Home and outpatient care</name>
        </item>
        <item>
          <name>Intergovernmental relations</name>
        </item>
        <item>
          <name>Manufacturing</name>
        </item>
        <item>
          <name>Medicaid</name>
        </item>
        <item>
          <name>Prescription drugs</name>
        </item>
        <item>
          <name>State and local government operations</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2020-02-12</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2021-01-09T00:40:04Z</updateDate>
        <text><![CDATA[ <p><b>Generating Effective and Novel Evidence for Therapy Payment Act or the GENE Therapy Payment Act</b></p> <p>This bill allows state Medicaid programs to pay for certain gene therapy drugs through risk-sharing value-based payment agreements with drug manufacturers. The bill applies to covered outpatient drugs that provide potentially curative treatment for serious or life-threatening rare diseases or conditions after not more than three administrations.</p>]]></text>
      </summary>
    </summaries>
    <title>GENE Therapy Payment Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>GENE Therapy Payment Act</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To amend title XIX of the Social Security Act to provide States with the option under the Medicaid program to pay for covered outpatient drugs through risk-sharing value-based agreements, and for other purposes.</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>GENE Therapy Payment Act</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>Generating Effective and Novel Evidence for Therapy Payment Act</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2020-02-12T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116hr5882ih/xml/BILLS-116hr5882ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2020-02-12</actionDate>
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
